Imaging Glioblastoma With 18F-Fluciclovine Amino Acid Positron Emission Tomography

Imaging Glioblastoma With 18F-Fluciclovine Amino Acid Positron Emission Tomography

IntroductionConventional methods of imaging brain tumors fail to assess metabolically active tumor regions, which limits their capabilities for tumor detection, localization, and response assessment. Positron emission tomography (PET) with 18F-fluciclovine (fluciclovine) provides regional assessment...

Full description

Bibliographic Details
Main Authors:	Matthew L. Scarpelli, Debbie R. Healey, Shwetal Mehta, C. Chad Quarles
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Oncology
Subjects:	positron emission tomography 18F-FACBC fluciclovine ASCT2 amino acid metabolism PET imaging
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.829050/full

Similar Items

Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis
by: Angelo Castello, et al.
Published: (2023-12-01)

Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer
by: Irena Saarinen, et al.
Published: (2019-05-01)

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas
by: Ephraim E. Parent, et al.
Published: (2018-07-01)

Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma
by: Volker Morath, et al.
Published: (2022-01-01)

Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
by: Xu Bin, et al.
Published: (2020-01-01)

[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis
by: Ephraim E. Parent, et al.
Published: (2020-12-01)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
by: Giuseppina Biscontini, et al.
Published: (2021-02-01)

Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial
by: Toshihiko Wakabayashi, et al.
Published: (2017-01-01)

Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
by: Kirsten Margrete Selnæs, et al.
Published: (2020-12-01)

Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging With 18F- Fluciclovine: A Comparison Study With L-Methyl-11C-Methionine PET Imaging
by: Naohiro Tsuyuguchi, et al.
Published: (2017-06-01)

Detection Rate and Clinical Impact of PET/CT with <sup>18</sup>F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
by: Luca Filippi, et al.
Published: (2022-01-01)

[<sup>18</sup>F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
by: Anna Giulia Nappi, et al.
Published: (2022-03-01)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
by: Tore Bach-Gansmo, et al.
Published: (2022-06-01)

[<sup>18</sup>F]fluciclovine vs. [<sup>18</sup>F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
by: Cristina Ferrari, et al.
Published: (2022-11-01)

The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
by: Rang Wang, et al.
Published: (2021-06-01)

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer
by: Yusuke Inoue, et al.
Published: (2014-10-01)

Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
by: Ivar S Jensen, et al.
Published: (2020-01-01)

18F-FACBC PET/MRI in the evaluation of human brain metastases: a case report
by: Knut Johannessen, et al.
Published: (2021-04-01)

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
by: Zuzana Balážová, et al.
Published: (2020-04-01)

MRI and amino acid PET detection of whole-brain tumor burden
by: Peng Chen, et al.
Published: (2023-09-01)

<sup>18</sup>F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis
by: Riccardo Laudicella, et al.
Published: (2019-09-01)

The Role of [<sup>18</sup>F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [<sup>11</sup>C]Choline PET/CT and Histopathological Analysis
by: Lucia Zanoni, et al.
Published: (2021-03-01)

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)
by: Pedro M. O. Gomes, et al.
Published: (2020-04-01)

Exploratory Analysis of Serial <sup>18</sup>F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma
by: Kavi Fatania, et al.
Published: (2022-07-01)

Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors
by: Aixia Sun, et al.
Published: (2018-01-01)

Clinical value of 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer
by: Bandar Alwadani, et al.
Published: (2021-07-01)

Recent Advances in <sup>18</sup>F-Labeled Amino Acids Synthesis and Application
by: Chao Wang, et al.
Published: (2022-10-01)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
by: Alexandra Nikaki, et al.
Published: (2019-01-01)

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
by: Morteza Esmaeili, et al.
Published: (2018-11-01)

Positron Emission Tomography with [18F]FLT Revealed Sevoflurane-induced Inhibition of Neural Progenitor Cell Expansion in vivo
by: Shuliang eLiu, et al.
Published: (2014-11-01)

18F-FLOURODEOXYGLUCOSE (18FDG) POSITRON-EMISSION TOMOGRAPHY (PET) AS IMAGING MODALITIES ON THYROID CANCER MANAGEMENT
by: I Putu Ary Wismayana, et al.
Published: (2013-07-01)

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
by: Jan-Michael Werner, et al.
Published: (2020-03-01)

Silicon-[18F]Fluorine Radiochemistry: Basics, Applications and Challenges
by: Carmen Wängler, et al.
Published: (2012-03-01)

Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors
by: B Schaller
Published: (2004-04-01)

Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
by: Caroline Bouter, et al.
Published: (2021-11-01)

18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
by: Michinori Ezura, et al.
Published: (2021-11-01)

The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
by: Silvia Taralli, et al.
Published: (2012-01-01)

Case Report: 18F-Fluoro-L-Phenylalanine Positron Emission Tomography Findings and Immunoreactivity for L-Type Amino Acid Transporter 1 in a Dog With Meningioma
by: Dohee Lee, et al.
Published: (2022-07-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
by: Chan Ju Ryu
Published: (2022-12-01)

In vitro evaluation of (S)-2-amino-3-[3-(2-18F-fluoroethoxy)-4-iodophenyl]-2-methylpropanoic acid (18F-FIMP) as a positron emission tomography probe for imaging amino acid transporters
by: Satoshi Nozaki, et al.
Published: (2023-04-01)